Explore comprehensive CRO services offered by Biocytogen, supporting end-to-end Drug Development. Biocytogen enables faster, compliant, and scalable pharma innovation tailored to your needs.
Country: China
Description: Biocytogen is a global biotechnology company focused on developing novel antibody-based drugs and providing preclinical CRO services. Founded in 2009 and headquartered in Beijing, the company uses gene editing to develop proprietary platforms, including RenMice® and the RenBiologics™ library, for drug discovery. It has a global presence with offices in China, the U.S., and Germany and partners with numerous pharmaceutical companies.
